| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-06 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |